wellness

Physician explaining what the 2026 FDA peptide news means for patients

Peptides Are Back in the News. Here Is What Actually Matters.

By the physicians of Amanecia Health | March 2026 Last reviewed June 18, 2026 by Ann Czarnik, M.D., FACEP. Updated to reflect the FDA’s April 2026 action. NPR reported this week on what many patients and clinicians have been waiting for: the government is moving closer to lifting restrictions on some of the most widely used […]

Peptides Are Back in the News. Here Is What Actually Matters. Read More »

Physician reviewing FDA peptide regulatory updates and clinical research

FDA Peptide Reclassification 2026: What It Means for Patients — and Why Physician Oversight Matters More Than Ever

By the physicians of Amanecia Health | Updated April 27, 2026 Last reviewed June 18, 2026 by Ann Czarnik, M.D., FACEP. This page is maintained as a living reference and updated as the FDA process develops. Related: Read our follow-up on the NPR report on peptide restrictions and what it means for patients. On February

FDA Peptide Reclassification 2026: What It Means for Patients — and Why Physician Oversight Matters More Than Ever Read More »